Literature DB >> 30031828

Clostridium difficile and Clostridioides difficile: Two validly published and correct names.

Aharon Oren1, Maja Rupnik2.   

Abstract

The current status of the names Clostridium difficile and Clostridioides difficile is explained in view of the current confusion about the correct name of this well-known pathogen. Both names have been validly published under the provisions of the Prokaryotic Code and both names can be used.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridioides difficile; Clostridium difficile; Nomenclature; Prokaryotic Code; Taxonomy

Mesh：

Year:  2018        PMID： 30031828     DOI： 10.1016/j.anaerobe.2018.07.005

Source DB:  PubMed          Journal:  Anaerobe        ISSN： 1075-9964            Impact factor:   3.331


  13 in total

1.  Evaluation of a Gastrointestinal Pathogen Panel Immunoassay in Stool Testing of Patients with Suspected Clostridioides (Clostridium) difficile Infection.

Authors:  Marcela Krutova; Ales Briksi; Jan Tkadlec; Miroslav Zajac; Jana Matejkova; Otakar Nyc; Pavel Drevinek
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

2.  Using an Endogenous CRISPR-Cas System for Genome Editing in the Human Pathogen Clostridium difficile.

Authors:  Anna Maikova; Victor Kreis; Anaïs Boutserin; Konstantin Severinov; Olga Soutourina
Journal:  Appl Environ Microbiol       Date:  2019-10-01       Impact factor: 4.792

Review 3.  Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.

Authors:  Alexander Khoruts; Christopher Staley; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-25       Impact factor: 46.802

4.  The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.

Authors:  Marcela Krutova; Vaclav Capek; Elka Nycova; Sabina Vojackova; Magda Balejova; Lenka Geigerova; Renata Tejkalova; Lenka Havlinova; Iva Vagnerova; Pavel Cermak; Lenka Ryskova; Petr Jezek; Dana Zamazalova; Denisa Vesela; Alice Kucharova; Dana Nemcova; Martina Curdova; Otakar Nyc; Pavel Drevinek
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-30       Impact factor: 4.887

5.  Generation of Markerless Deletions in the Nosocomial Pathogen Clostridium difficile by Induction of DNA Double-Strand Breaks.

Authors:  Elena-Stella Theophilou; Prerna Vohra; Maurice P Gallagher; Ian R Poxton; Garry W Blakely
Journal:  Appl Environ Microbiol       Date:  2019-01-23       Impact factor: 4.792

6.  Clostridioides difficile infection in the Asia-Pacific region.

Authors:  Deirdre A Collins; Kyung Mok Sohn; Yuan Wu; Kentaro Ouchi; Yoshikazu Ishii; Briony Elliott; Thomas V Riley; Kazuhiro Tateda
Journal:  Emerg Microbes Infect       Date:  2019-12-24       Impact factor: 7.163

Review 7.  Clostridioides (Clostridium) Difficile in Food-Producing Animals, Horses and Household Pets: A Comprehensive Review.

Authors:  Melina Kachrimanidou; Eleni Tzika; George Filioussis
Journal:  Microorganisms       Date:  2019-12-09

Review 8.  Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases.

Authors:  Gianluca Quaranta; Maurizio Sanguinetti; Luca Masucci
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

9.  A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile.

Authors:  William E Matchett; Stephanie Anguiano-Zarate; Goda Baddage Rakitha Malewana; Haley Mudrick; Melissa Weldy; Clayton Evert; Alexander Khoruts; Michael Sadowsky; Michael A Barry
Journal:  Vaccines (Basel)       Date:  2020-08-22

10.  Low-density lipoprotein receptor-related protein 1 is a CROPs-associated receptor for Clostridioides infection toxin B.

Authors:  Shengjie Guo; Yiou Chen; Jingze Liu; Xinyi Zhang; Zhiheng Liu; Zhuo Zhou; Wensheng Wei
Journal:  Sci China Life Sci       Date:  2021-07-15       Impact factor: 6.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.